Sesen Bio, Inc. announced an increase of the one-time special cash dividend expected to be paid to stockholders to $75.0 million, or approximately $0.36 per share. This represents an increase from the expected special cash dividend of approximately $70.0 million, or approximately $0.34 per share1, under the first amendment to the merger agreement, and an increase from the up to $25.0 million special cash dividend under the terms of the original merger agreement dated September 20, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | -2.56% | +5.56% | -61.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.09% | 4.74Cr | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.07% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Sesen Bio, Inc. Announces Increase of One-Time Special Cash Dividend